Bernhard Landwehrmeyer

LWM2014

Georg Bernhard Landwehrmeyer, MD, PhD, FRCP

email: bernhard.landwehrmeyer@uni-ulm.de

Georg Bernhard Landwehrmeyer, MD, PhD, FRCP, is currently Full Professor of Neurology “Clinical Neurobiology” at the Ulm University Hospital. As one of the founders of the EHDN (European Huntington’s Disease Network), he was Chair for 10 years of the Executive Committee. EHDN is devoted to clinical and basic studies on Huntington’s Disease while providing a platform for professionals and people affected by HD and their relatives to facilitate working together throughout Europe. He is also Consulting Medical Director at the CHDI Foundation where he coordinates the scientific work in Europe on behalf of CHDI Foundation. He has the role of Global PI at Enroll-HD: the worldwide observational study for Huntington’s disease families – the Prospective Registry Study in a Global HD Cohort.

Prof. Landwehrmeyer received his degrees in the M.D. and his Doctorial Thesis at the Albert-Ludwigs-University in Freiburg, Germany. He has also studied at the Royal Victoria Hospital, Queen’s University in Belfast, UK, Kantonsspital in Basel, Switzerland and at MGH and Harvard Medical School, Boston. From 1995 – 1999, he was a staff member at the Albert-Ludwigs-University in Freiburg, Medical in Residency School (Departments of Neurology and Psychiatry). 1999 he received his Board Certification in Neurology and a year later the Venia Legendi and full Professorship (‘C3’) in Neurology at the University of Ulm. Dr. Landwehrmeyer’s background includes pathology and pharmacology aside from clinical neurology. His research interests are focused on neurodegenerative disorders with a special emphasis on movement disorders like Parkinson’s and Huntington’s disease and range from bench work to clinical studies. He continues to show his expertise especially in the field of Huntington’s Disease in numerous clinical trials and researches both nationally and internationally.